Revelation Biosciences, Inc.
REVB
$3.40
$0.061.80%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.82% | -17.03% | 21.35% | -14.31% | -10.93% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -6.28% | 74.83% | -15.11% | -44.50% | -38.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -45.41% | -16.58% | 20.38% | -14.13% | -11.37% |
|
|
|||||
| Total Current Assets | -45.41% | -16.58% | 20.38% | -14.13% | -11.37% |
| Net Property, Plant & Equipment | 14.69% | -9.23% | 19.82% | -8.70% | -8.12% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -45.07% | -16.54% | 20.38% | -14.11% | -11.35% |
|
|
|||||
| Total Accounts Payable | 144.07% | -23.81% | 23.66% | 8.17% | 37.56% |
| Total Accrued Expenses | -88.95% | 1,262.91% | -46.18% | 12.77% | 105.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -99.66% | -52.38% | -4.13% | -2.19% | -2.88% |
| Total Other Current Liabilities | -99.66% | -52.38% | -4.13% | -2.19% | -2.88% |
| Total Current Liabilities | -63.46% | 112.86% | -6.05% | 3.05% | 16.78% |
|
|
|||||
| Total Current Liabilities | -63.46% | 112.86% | -6.05% | 3.05% | 16.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -63.46% | 112.86% | -6.05% | 3.05% | 16.78% |
|
|
|||||
| Common Stock & APIC | 10.02% | 0.15% | 17.15% | 0.10% | 0.10% |
| Retained Earnings | -6.13% | -29.81% | -10.53% | -9.47% | -12.74% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 134.44% | -87.96% | 42.50% | -24.62% | -22.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 134.44% | -87.96% | 42.50% | -24.62% | -22.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 134.44% | -87.96% | 42.50% | -24.62% | -22.75% |
|
|
|||||
